Kansai Nerolac Paints Ltd (KANSAINER) Q1 FY27 Results Analysis: Revenue Surges 10.2%, Margin Exceeds Guidance

CompoundingAI Research Updated August 03, 2026 2 min read
Positive

Kansai Nerolac Paints Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 2,299.52 Cr (+10.20% YoY) and PAT growth of +5.00% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 03, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 2,299.52 Cr (+10.20% YoY)
PAT (Q1)Rs. 242.34 Cr (+5.00% YoY)
EBITDA margin14.61% (-34 bps YoY)
EPS (Q1)Rs. 3.00 (+4.90% YoY)
Market capRs. 16,503.11 Cr
CMPRs. 204.18

Quarter Snapshot

Kansai Nerolac reported strong revenue growth of 10.2% YoY, the highest in recent quarters, and EBITDA margin of 14.61% exceeded the guided range of 13-14% despite significant raw material cost inflation. The company's price hikes and cost control measures partially offset the impact, but earnings growth lagged revenue growth. The outlook remains cautious due to persistent raw material and forex headwinds.

Key Investment Insights

Key Positives

  • Revenue grew 10.2% YoY to Rs.2,299.52 Cr, the highest quarterly growth in recent quarters
  • EBITDA margin of 14.61% exceeded the guided range of 13-14%
  • PAT grew 5.0% YoY to Rs.242.34 Cr with no exceptional items
  • Four rounds of decorative price hikes (high single digits cumulative) implemented to offset raw material inflation
  • Demand in Decorative and Industrial segments was healthy

Risk Factors

  • Raw material cost surged 29.1% YoY, increasing net raw material cost ratio by 1.08 pp YoY
  • EBITDA growth at 7.7% lagged revenue growth of 10.2%, compressing EBITDA margin by 34 bps YoY
  • Subsidiaries remained loss-making, dragging consolidated PAT by Rs.10.76 Cr
  • Rupee depreciation and West Asia supply chain disruptions added cost pressure
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now